<DOC>
	<DOCNO>NCT00289822</DOCNO>
	<brief_summary>Impaired contractile function heart attack due coronary heart disease major cause `` heart failure '' limiting quality life prognosis , prevent even optimal standard therapy . The aim current trial investigate whether infusion progenitor cell coronary artery supply dyskinetic leave ventricular area may improve leave ventricular contractile function , compare cell infusion control group , patient old ( &gt; = 3 month ) myocardial infarction .</brief_summary>
	<brief_title>Cell Therapy Coronary Heart Disease</brief_title>
	<detailed_description>- The study open-label , control , randomize single-center trial . - Patients post myocardial infarction ( &gt; = 3 month ) patent infarct-related artery include . - Bone marrow-derived progenitor cell aspirate local anaesthesia , cell processing , infused patent infarct-related artery stop flow within day . Blood-derived progenitor cell isolate 250ml peripheral venous blood , cell process 3 day culture , infused patent infarct-related artery stop flow . In addition , leave ventricular angiography perform . In control group coronary angiography leave ventricular angiography without intracoronary infusion perform . - After 3 month , leave ventricular angiography repeat , patient control group cross-over active treatment progenitor cell , whereas patient initially treat progenitor cell cross-over alternate cell type . - The primary endpoint change quantitative global leave ventricular ejection fraction LV angiography group .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Patients age 18 80 Patients postmyocardial infarction ( &gt; 3 month old ) diffuse ischemic CHD Signed inform consent Existing neoplastic disease sign tumor recurrence within last 5 year Active infection Active internal bleeding Stroke within past 2 year Surgery trauma within past two month Uncontrolled hypertension 160/100 Arteriovenous malformation aneurysms HIV infection Signs significant kidney liver failure ( creatinine &gt; 2.0 mg/dL , GOT &gt; 2 x upper standard value ) Thrombopenia ( &lt; 100,000 ) Anemia ( hemoglobin &lt; 8.5 g/dL ) Mental retardation Participation another clinical study Women childbearing age Chronic inflammatory disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2006</verification_date>
	<keyword>chronic heart failure</keyword>
	<keyword>myocardial infarction</keyword>
</DOC>